Tissue-specificity of insulin action and resistance*

Manuel Benito**aa Departamento de Bioquímica y Biología Molecular II, Facultad de Farmacia, Universidad Complutenseb 28040-Madrid and CIBER de Diabetes y Enfermedades Metabólicas Asociadas, ISCIII, Spain*Devoted to the beloved memory of Margarita Lorenzo.Correspondence to: Manuel Benito. Departamento de Bioquímica y Biología Molecular II, Facultad de Farmacia, Universidad Complutense, 28040-Madrid (Spain). Tel: 34–91-3941777. Fax: 34–91-3941779. E-mail: benito@farm.ucm.esInsulin resistance is the most important pathophysiological feature in many pre-diabetic states. Type 2 diabetes mellitus is a complex metabolic disease and its pathogenesis involves abnormalities in both peripheral insulin action and insulin secretion by pancreatic beta cells. The creation of monogenic or polygenic genetically manipulated mice models in a tissue-specific manner was of great help to elucidate the tissue-specificity of insulin action and its contribution to the overall insulin resistance. However, complete understanding of the molecular bases of the insulin action and resistance requires the identification of the intracellular pathways that regulate insulin-stimulated proliferation, differentiation and metabolism. Accordingly, cell lines derived from insulin target tissues such as brown adipose tissue, liver and beta islets lacking insulin receptors or sensitive candidate genes such as IRS-1, IRS-2, IRS-3, IR and PTP1B were developed. Indeed, these cell lines have been also very useful to understand the tissue-specificity of insulin action and inaction.